Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asia Stem Cell Center (ASCC) is a specialized regenerative medicine facility and laboratory based in Bangkok, Thailand. The center focuses on the clinical application of Mesenchymal Stem Cells (MSCs), primarily derived from umbilical cord tissue, for anti-aging, aesthetic rejuvenation, and the treatment of chronic degenerative diseases. ASCC operates its own advanced laboratory to ensure high standards of cell cultivation, safety, and quality control. Their service portfolio includes personalized regenerative protocols for joint health, autoimmune disorders, and systemic wellness. The organization serves as a key provider of cell-based therapies in the Southeast Asian region, catering to both local and international patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asia Stem Cell Center.